Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

634 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A comparison of acyl-moieties for noncovalent functionalization of PLGA and PEG-PLGA nanoparticles with a cell-penetrating peptide.
Paulino da Silva Filho O, Ali M, Nabbefeld R, Primavessy D, Bovee-Geurts PH, Grimm S, Kirchner A, Wiesmüller KH, Schneider M, Walboomers XF, Brock R. Paulino da Silva Filho O, et al. Among authors: grimm s. RSC Adv. 2021 Nov 10;11(57):36116-36124. doi: 10.1039/d1ra05871a. eCollection 2021 Nov 4. RSC Adv. 2021. PMID: 35492790 Free PMC article.
Challenges in the Assessment of a Disease Model in the NICE Single Technology Appraisal of Tirzepatide for Treating Type 2 Diabetes: An External Assessment Group Perspective.
Scholte M, Ramaekers B, Danopoulos E, Grimm SE, Fernandez Coves A, Tian X, Debray T, Chen J, Stirk L, Croft R, Joore M, Armstrong N. Scholte M, et al. Among authors: grimm se. Pharmacoeconomics. 2024 May 8. doi: 10.1007/s40273-024-01394-8. Online ahead of print. Pharmacoeconomics. 2024. PMID: 38717708 No abstract available.
Bayesian Hierarchical Modelling for Histology-Independent Time-to-Event Outcomes in the NICE Single Technology Appraisal of Pembrolizumab for Solid Tumours with MSI-H/dMMR: External Assessment Group Perspective.
Sugden BM, Grimm SE, Wolff R, Armstrong N, Otten T, Abu-Zahra T, Perry M, Patel M, Chen J, Noake C, Joore M, Witlox WJA. Sugden BM, et al. Among authors: grimm se. Pharmacoeconomics. 2024 May 7. doi: 10.1007/s40273-024-01381-z. Online ahead of print. Pharmacoeconomics. 2024. PMID: 38713424 No abstract available.
The CD33xCD123xCD70 Multispecific CD3-Engaging DARPin MP0533 Induces Selective T Cell-Mediated Killing of AML Leukemic Stem Cells.
Bianchi M, Reichen C, Croset A, Fischer S, Eggenschwiler A, Grübler Y, Marpakwar R, Looser T, Spitzli P, Herzog C, Villemagne D, Schiegg D, Abduli L, Iss C, Neculcea A, Franchini M, Lekishvili T, Ragusa S, Zitt C, Kaufmann Y, Auge A, Hänggi M, Ali W, Frasconi TM, Wullschleger S, Schlegel I, Matzner M, Lüthi U, Schlereth B, Dawson KM, Kirkin V, Ochsenbein AF, Grimm S, Reschke N, Riether C, Steiner D, Leupin N, Goubier A. Bianchi M, et al. Among authors: grimm s. Cancer Immunol Res. 2024 Apr 29. doi: 10.1158/2326-6066.CIR-23-0692. Online ahead of print. Cancer Immunol Res. 2024. PMID: 38683145 Free article.
634 results